united states liquid biopsy potential testing market

14
© Renub Research Page 1 of 14 United States Liquid Biopsy Potential Testing Market & Volume Analysis to 2020 Renub Research www.renub.com Published: January, 2016 Copyright © 2016 Renub Research All Rights Reserved Lung Cancer Breast Cancer Colorectal Cancer Prostate Cancer Liver Cancer Other Cancers

Upload: renub-research

Post on 18-Feb-2017

137 views

Category:

Health & Medicine


1 download

TRANSCRIPT

Page 1: United states liquid biopsy potential testing market

© Renub Research Page 1 of 14

United States – Liquid Biopsy Potential

Testing Market & Volume Analysis to 2020

Renub Researchwww.renub.com

Published: January, 2016Copyright © 2016 Renub Research – All Rights Reserved

Lung Cancer

Breast Cancer

Colorectal Cancer

Prostate Cancer

Liver Cancer

Other Cancers

Page 2: United states liquid biopsy potential testing market

© Renub Research Page 2 of 14

United States – Liquid Biopsy Testing Market - Overview

Liquid Biopsy Tests are emerging as a viable alternative to traditional methods for cancer

screening. A liquid biopsy is a new type of blood test that has the potential to transform

cancer treatment. Using this methodology, physicians avoid the traditional surgical and needle

biopsies they use to determine the existence of cancer in patients. In United States Liquid

Biopsy market; Screening Test is likely to capture major chunk of the market compared to

Monitoring Market. It is anticipated that Liquid Biopsy Testing will be more helpful for

monitoring cancer treatment and status after diagnosis than in screening for a cancer that may

be years or even decades in the making and not otherwise detectable.

United States – Liquid Biopsy Potential Screening Market Analysis: In the United States liquid

biopsy screening market, prostate cancer is the most popular segment. Lung cancer liquid

biopsy screening stands at the last spot.

United States – Liquid Biopsy Potential Treatment Monitoring Market Analysis: In the United

States liquid biopsy treatment monitoring market, breast cancer is the leading segment. Liver

cancer stands at the fifth spot.

Renub Research report titled “United States – Liquid Biopsy Potential Testing Market &

Volume Analysis to 2020” provides a comprehensive assessment of the fast–evolving, high–

growth of Liquid Biopsy Market. This 79 page report with 41 Figures analyses the United

States Liquid Biopsy Test Market and Volume by 5 Top Cancer Segment, Recent developments,

Major Deals along with the driving factors and challenges for Liquid Biopsy Market.

The United States Liquid Biopsy Potential Market has been analyzed from two view points

1. United States Liquid Biopsy Potential Screening Market & Test Volume (2015 – 2020)

The Top 5 Cancer Segments covered are:

1. Lung Cancer

2. Breast Cancer

Page 3: United states liquid biopsy potential testing market

© Renub Research Page 3 of 14

3. Colorectal Cancer

4. Prostate Cancer

5. Liver Cancer

2. United States Liquid Biopsy Potential Treatment Monitoring Market & Test Volume (2015

– 2020)

The Top 6 Cancer Segments covered are:

1. Lung Cancer

2. Breast Cancer

3. Colorectal Cancer

4. Prostate Cancer

5. Liver Cancer

6. Other Cancers

Data Sources

This report is built using data and information sourced from proprietary databases, primary and

secondary research and in–house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non–

printable sources like search engines, News websites, Government Websites, Trade Journals,

White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books,

Industry Portals, Industry Associations and access to more than 500 paid databases.

Page 4: United states liquid biopsy potential testing market

© Renub Research Page 4 of 14

About Us

RReennuubb RReesseeaarrcchh is a leading Market Research and Information Analysis Company with

centers at Noida India and Roswell USA. We have long–term experience especially in

international Business–to–Business Researches, Surveys, Business and Consulting. Throughout

the years we have acquired expertise in most market sectors, including Information Technology

(IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking,

Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer

Goods, Logistics, Governmental, Social, and Others.

Our core team is comprised of an experienced people holding graduate, post graduate and

Ph.D. degrees in Finance, Marketing, Human Resource, Bio–Technology, Medicine, Information

Technology, Environmental Science and many more. Our research help make the business

decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We

support many blue chip companies by providing them findings and perspectives across a wide

range of markets. Our research reports offer a blend of information insight, analysis and

forecasting that is essential in today’s ultra–competitive markets.

For more information on us or to view any of our sample work you can mail

us at [email protected]

Page 5: United states liquid biopsy potential testing market

© Renub Research Page 5 of 14

Published

By

RReennuubb RReesseeaarrcchh

1st Floor,

C – 86, Sector – 10

Noida – 201301

Phone: +91–120–421–9822, 424-9780 (India)

+1–678–302–0700 (USA)

Email: [email protected]

www.renub.com

© United States – Liquid Biopsy Potential Testing Market & Volume Analysis to 2020

Renub Research, 2016

Edition 1.0

All rights reserved. This publication is protected

by copyright. No part of it may be reproduced, stored

in a retrieval system or transmitted, in any form or by

any means, electronic mechanical, photocopying,

recording or otherwise without the prior written

permission of the publishers

Page 6: United states liquid biopsy potential testing market

© Renub Research Page 6 of 14

Table of Contents

1. Executive Summary

2. United States - Liquid Biopsy Potential Market (2015 – 2020)

2.1 United States - Liquid Biopsy Potential Market

2.2 United States - Liquid Biopsy Screening Potential Market

2.3 United States - Liquid Biopsy Treatment Monitoring Potential Market

3. United States - Liquid Biopsy Potential Test Volume (2015 – 2020)

3.1 United States - Liquid Biopsy Potential Test Volume

3.2 United States - Liquid Biopsy Potential Screening Test Volume

3.3 United States - Liquid Biopsy Potential Treatment Monitoring Test Volume

4. United States - Liquid Biopsy Potential Market Share (2015 – 2020)

4.1 United States - Liquid Biopsy Potential Market Share by Method

4.2 United States - Liquid Biopsy Screening Potential Market Share by Cancer Types

4.3 United States - Liquid Biopsy Treatment Monitoring Potential Market Share by Cancer Types

5. United States - Liquid Biopsy Potential Market & Test Volume by Cancer Types (2015 – 2020)

5.1 United States - Liquid Biopsy Lung Cancer Potential Market & Test Volume

5.1.1 United States - Liquid Biopsy Lung Cancer Potential Market

5.1.2 United States - Liquid Biopsy Lung Cancer Potential Test Volume

5.2 United States - Liquid Biopsy Breast Cancer Potential Market & Test Volume

5.2.1 United States - Liquid Biopsy Breast Cancer Potential Market

5.2.2 United States - Liquid Biopsy Breast Cancer Potential Test Volume

5.3 United States - Liquid Biopsy Colorectal Cancer Potential Market & Test Volume

5.3.1 United States - Liquid Biopsy Colorectal Cancer Potential Market

5.3.2 United States - Liquid Biopsy Colorectal Cancer Potential Test Volume

Page 7: United states liquid biopsy potential testing market

© Renub Research Page 7 of 14

5.4 United States - Liquid Biopsy Prostate Cancer Potential Market & Test Volume

5.4.1 United States - Liquid Biopsy Prostate Cancer Potential Market

5.4.2 United States - Liquid Biopsy Prostate Cancer Potential Test Volume

5.5 United States - Liquid Biopsy Liver Cancer Potential Market & Test Volume

5.5.1 United States - Liquid Biopsy Liver Cancer Potential Market

5.5.2 United States - Liquid Biopsy Liver Cancer Potential Test Volume

6. United States - Liquid Biopsy Screening Potential Market & Test Volume by Cancer Types

(2015 – 2020)

6.1 United States - Liquid Biopsy Lung Cancer Screening Potential Market & Test Volume

6.1.1 United States - Liquid Biopsy Lung Cancer Screening Potential Market

6.1.2 United States - Liquid Biopsy Lung Cancer Screening Potential Test Volume

6.2 United States - Liquid Biopsy Breast Cancer Screening Potential Market & Test Volume

6.2.1 United States - Liquid Biopsy Breast Cancer Screening Potential Market

6.2.2 United States - Liquid Biopsy Breast Cancer Screening Potential Test Volume

6.3 United States - Liquid Biopsy Colorectal Cancer Screening Potential Market & Test Volume

6.3.1 United States - Liquid Biopsy Colorectal Cancer Screening Potential Market

6.3.2 United States - Liquid Biopsy Colorectal Cancer Screening Potential Test Volume

6.4 United States - Liquid Biopsy Prostate Cancer Screening Potential Market & Test Volume

6.4.1 United States - Liquid Biopsy Prostate Cancer Screening Potential Market

6.4.2 United States - Liquid Biopsy Prostate Cancer Screening Potential Test Volume

6.5 United States - Liquid Biopsy Liver Cancer Screening Potential Market & Test Volume

6.5.1 United States - Liquid Biopsy Liver Cancer Screening Potential Market

6.5.2 United States - Liquid Biopsy Liver Cancer Screening Potential Test Volume

7. United States - Liquid Biopsy Treatment Monitoring Potential Market & Test Volume by Cancer

Types (2015 – 2020)

Page 8: United states liquid biopsy potential testing market

© Renub Research Page 8 of 14

7.1 United States - Liquid Biopsy Lung Cancer Treatment Monitoring Potential Market & Test Volume

7.1.1 United States - Liquid Biopsy Lung Cancer Treatment Monitoring Potential Market

7.1.2 United States - Liquid Biopsy Lung Cancer Treatment Monitoring Potential Test Volume

7.2 United States - Liquid Biopsy Breast Cancer Treatment Monitoring Potential Market & Test

Volume

7.2.1 United States - Liquid Biopsy Breast Cancer Treatment Monitoring Potential Market

7.2.2 United States - Liquid Biopsy Breast Cancer Treatment Monitoring Potential Test Volume

7.3 United States - Liquid Biopsy Colorectal Cancer Treatment Monitoring Potential Market & Test

Volume

7.3.1 United States - Liquid Biopsy Colorectal Cancer Treatment Monitoring Potential Market

7.3.2 United States - Liquid Biopsy Colorectal Cancer Treatment Monitoring Potential Test

Volume

7.4 United States - Liquid Biopsy Prostate Cancer Treatment Monitoring Potential Market & Test

Volume

7.4.1 United States - Liquid Biopsy Prostate Cancer Treatment Monitoring Potential Market

7.4.2 United States - Liquid Biopsy Prostate Cancer Treatment Monitoring Potential Test Volume

7.5 United States - Liquid Biopsy Liver Cancer Treatment Monitoring Potential Market & Test Volume

7.5.1 United States - Liquid Biopsy Liver Cancer Treatment Monitoring Potential Market

7.5.2 United States - Liquid Biopsy Liver Cancer Treatment Monitoring Potential Test Volume

7.6 United States - Liquid Biopsy Other Cancers Treatment Monitoring Potential Market & Test

Volume

7.6.1 United States - Liquid Biopsy Other Cancers Treatment Monitoring Potential Market

7.6.2 United States - Liquid Biopsy Other Cancers Treatment Monitoring Potential Test Volume

8. Liquid Biopsy Market – Recent Development

9. Liquid Biopsy Market – Major Deals Analysis

10. Liquid Biopsy Market – Driving Factors

Page 9: United states liquid biopsy potential testing market

© Renub Research Page 9 of 14

10.1 Real-Time Evaluation, Convenient and Accuracy

10.2 Increasing Demand for Minimally-Invasive Biopsy Techniques

10.3 Technical Advancement & Personalized Therapies

11. Liquid Biopsy Market – Challenges

11.1 Barriers for Liquid Biopsies

11.1.1 Comparatively Low Concentration of Molecular Biomarkers in Body Fluids

11.1.2 Low Concentration of Target DNA in A Plasma Sample

11.1.3 Proper Handling and Storage of the Samples Critical

List of Figures:

Figure 2-1: United States - Liquid Biopsy Potential Market (Million US$), 2015 - 2020

Figure 2-2: United States - Liquid Biopsy Screening Potential Market (Million US$), 2015 - 2020

Figure 2-3: United States - Liquid Biopsy Treatment Monitoring Potential Market (Million US$), 2015 - 2020

Figure 3-1: United States - Liquid Biopsy Potential Test Volume (Number), 2015 - 2020

Figure 3-2: United States - Liquid Biopsy Potential Screening Test Volume (Number), 2015 - 2020

Figure 3-3: United States - Liquid Biopsy Potential Treatment Monitoring Test Volume (Number), 2015 -

2020

Figure 4-1: United States – Method Wise Liquid Biopsy Potential Market Share (Percent), 2015 - 2020

Figure 4-2: United States - Liquid Biopsy Screening Potential Market Share by Cancer Types (Percent),

2015 - 2020

Figure 4-3: United States - Liquid Biopsy Treatment Monitoring Potential Market Share by Cancer Types

(Percent), 2015 - 2020

Figure 5-1: United States - Liquid Biopsy Lung Cancer Potential Market (Million US$), 2015 - 2020

Figure 5-2: United States - Liquid Biopsy Lung Cancer Potential Test Volume (Number), 2015 - 2020

Figure 5-3: United States - Liquid Biopsy Breast Cancer Potential Market (Million US$), 2015 - 2020

Figure 5-4: United States - Liquid Biopsy Breast Cancer Potential Test Volume (Number), 2015 - 2020

Figure 5-5: United States - Liquid Biopsy Colorectal Cancer Potential Market (Million US$), 2015 - 2020

Figure 5-6: United States - Liquid Biopsy Colorectal Cancer Potential Test Volume (Number), 2015 - 2020

Figure 5-7: United States - Liquid Biopsy Prostate Cancer Potential Market (Million US$), 2015 - 2020

Page 10: United states liquid biopsy potential testing market

© Renub Research Page 10 of 14

Figure 5-8: United States - Liquid Biopsy Prostate Cancer Potential Test Volume (Number), 2015 - 2020

Figure 5-9: United States - Liquid Biopsy Liver Cancer Potential Market (Million US$), 2015 - 2020

Figure 5-10: United States - Liquid Biopsy Liver Cancer Potential Test Volume (Number), 2015 - 2020

Figure 6-1: United States - Liquid Biopsy Lung Cancer Screening Potential Market (Million US$), 2015 -

2020

Figure 6-2: United States - Liquid Biopsy Lung Cancer Screening Potential Test Volume (Number), 2015 -

2020

Figure 6-3: United States - Liquid Biopsy Breast Cancer Screening Potential Market (Million US$), 2015 -

2020

Figure 6-4: United States - Liquid Biopsy Breast Cancer Screening Potential Test Volume (Number), 2015 -

2020

Figure 6-5: United States - Liquid Biopsy Colorectal Cancer Screening Potential Market (Million US$), 2015

- 2020

Figure 6-6: United States - Liquid Biopsy Colorectal Cancer Screening Potential Test Volume (Number),

2015 - 2020

Figure 6-7: United States - Liquid Biopsy Prostate Cancer Screening Potential Market (Million US$), 2015 -

2020

Figure 6-8: United States - Liquid Biopsy Prostate Cancer Screening Potential Test Volume (Number),

2015 - 2020

Figure 6-9: United States - Liquid Biopsy Liver Cancer Screening Potential Market (Million US$), 2015 -

2020

Figure 6-10: United States - Liquid Biopsy Liver Cancer Screening Potential Test Volume (Number), 2015

– 2020

Figure 7-1: United States - Liquid Biopsy Lung Cancer Treatment Monitoring Potential Market (Million

US$), 2015 - 2020

Figure 7-2: United States - Liquid Biopsy Lung Cancer Treatment Monitoring Potential Test Volume

(Number), 2015 - 2020

Figure 7-3: United States - Liquid Biopsy Breast Cancer Treatment Monitoring Potential Market (Million

US$), 2015 - 2020

Figure 7-4: United States - Liquid Biopsy Breast Cancer Treatment Monitoring Potential Test Volume

(Number), 2015 - 2020

Figure 7-5: United States - Liquid Biopsy Colorectal Cancer Treatment Monitoring Potential Market (Million

US$), 2015 - 2020

Figure 7-6: United States - Liquid Biopsy Colorectal Cancer Treatment Monitoring Potential Test Volume

(Number), 2015 - 2020

Page 11: United states liquid biopsy potential testing market

© Renub Research Page 11 of 14

Figure 7-7: United States - Liquid Biopsy Prostate Cancer Treatment Monitoring Potential Market (Million

US$), 2015 - 2020

Figure 7-8: United States - Liquid Biopsy Prostate Cancer Treatment Monitoring Potential Test Volume

(Number), 2015 - 2020

Figure 7-9: United States - Liquid Biopsy Liver Cancer Treatment Monitoring Potential Market (Million

US$), 2015 - 2020

Figure 7-10: United States - Liquid Biopsy Liver Cancer Treatment Monitoring Potential Test Volume

(Number), 2015 - 2020

Figure 7-11: United States - Liquid Biopsy Other Cancers Treatment Monitoring Potential Market (Million

US$), 2015 - 2020

Figure 7-12: United States - Liquid Biopsy Other Cancers Treatment Monitoring Potential Test Volume

(Number), 2015 - 2020

Page 12: United states liquid biopsy potential testing market

© Renub Research Page 12 of 14

Order Form

Scan and e-mail this page to [email protected], alternatively one can also write the Contact

Information in an e-mail and mail it. Else you can also fax this form to +91-120-424-9780

Questions? Please call +91-120-421-9822 (India), +1-678-302-0700 (USA) or mail to

[email protected]

Format

Report Title:

1. Liquid Biopsy Potential Testing Market & Volume Analysis to 2020 -

United States

Single User (Email from Publisher)

Hard Copy (Mail Delivery)

CD – Rom (Mail Delivery)

Global Site License (Multiple User License)

US$ 900 US$ 1000 US$ 1000 US$ 1400

For ordering this report: Easy ways to place your order:

1) Order online by Credit Card (Visa, MasterCard, etc.):

http://www.renub.com/united-states-liquid-biopsy-potential-testing-market-

and-volume-analysis-to-2020-515-p.php

Page 13: United states liquid biopsy potential testing market

© Renub Research Page 13 of 14

Bank Details

Account Name: Renub Research

A/C No.: 109102000023296

Name of Bank: IDBI Bank Ltd.

Swift Code: IBKLINBB010

Bank Address: 4th Floor

Indian Red Cross Building

1 Red Cross Road

Opposite Parliament Street

New Delhi – 110001

India

Contact Information

First Name: Last Name:

Email:

Job Title:

Company:

Address:

City:

Postal/Zip Code:

Country:

Phone:

Mobile:

Fax:

Report Format:

Your message:

Page 14: United states liquid biopsy potential testing market

© Renub Research Page 14 of 14

3) Order by Check

Please post the check accompanied by this form, to:

Company Address: Renub Research

1st Floor

C-86, Sector -10

Noida - 201301

Uttar Pradesh

India

Phone: +91-120-421-9822, 424-9780

For free Sample copy report or to view any of our sample work please contact us at

[email protected] or call +91-120-421-9822 (India), +1-678-302-0700 (USA)

Follow Us

Facebook: https://www.facebook.com/RenubResearch

LinkedIn: https://www.linkedin.com/company/renub-research

Twitter: https://twitter.com/renubresearch

Google+: https://plus.google.com/+renubresearch